Microencapsulation of Imatinib Methanesulfonate
- 作者: Ignatovich Z.V.1, Golubeva M.B.2, Koroleva E.V.1, Agabekov V.E.1, Gilevskaya K.S.1
-
隶属关系:
- Institute of the Chemistry of New Materials, National Academy of Sciences of Belarus
- Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus
- 期: 卷 51, 编号 6 (2017)
- 页面: 486-490
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244666
- DOI: https://doi.org/10.1007/s11094-017-1639-7
- ID: 244666
如何引用文章
详细
(Protamine—pectin)4 and (protamine—pectin)8 microcapsules and those containing also Ag nanoparticles were formed using the polyelectrolyte layer-by-layer (LbL) self-assembly method. The efficiency of imatinib methanesulfonate encapsulation in the microcapsules was 85.0 ± 6.0%. Microcapsules containing up to 50 mass% imatinib methanesulfonate and providing a prolonged release profile of the encapsulated drug were prepared. Encapsulation of imatinib in microcapsules increased its cytostatic activity (IC50 values reduced by 1.2 – 3.5 times) as compared with the free drug on the Molt-4, K-562, and KG-1 cell lines.
作者简介
Zh. Ignatovich
Institute of the Chemistry of New Materials, National Academy of Sciences of Belarus
Email: k_hilevskay@mail.ru
白俄罗斯, Minsk, 220141
M. Golubeva
Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus
Email: k_hilevskay@mail.ru
白俄罗斯, Minsk, 220141
E. Koroleva
Institute of the Chemistry of New Materials, National Academy of Sciences of Belarus
Email: k_hilevskay@mail.ru
白俄罗斯, Minsk, 220141
V. Agabekov
Institute of the Chemistry of New Materials, National Academy of Sciences of Belarus
Email: k_hilevskay@mail.ru
白俄罗斯, Minsk, 220141
K. Gilevskaya
Institute of the Chemistry of New Materials, National Academy of Sciences of Belarus
编辑信件的主要联系方式.
Email: k_hilevskay@mail.ru
白俄罗斯, Minsk, 220141
补充文件
